Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2003 3
2006 2
2007 3
2008 1
2009 4
2010 4
2011 4
2012 9
2013 7
2014 7
2015 5
2016 6
2017 4
2018 2
2019 2
2020 1
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
College of American Pathologists Tumor Regression Grading System for Long-Term Outcome in Patients with Locally Advanced Rectal Cancer.
Chen HY, Feng LL, Li M, Ju HQ, Ding Y, Lan M, Song SM, Han WD, Yu L, Wei MB, Pang XL, He F, Liu S, Zheng J, Ma Y, Lin CY, Lan P, Huang MJ, Zou YF, Yang ZL, Wang T, Lang JY, Orangio GR, Poylin V, Ajani JA, Wang WH, Wan XB. Chen HY, et al. Among authors: han wd. Oncologist. 2021 May;26(5):e780-e793. doi: 10.1002/onco.13707. Epub 2021 Feb 22. Oncologist. 2021. PMID: 33543577 Free PMC article.
Genetically engineered T cells for cancer immunotherapy.
Li D, Li X, Zhou WL, Huang Y, Liang X, Jiang L, Yang X, Sun J, Li Z, Han WD, Wang W. Li D, et al. Among authors: han wd. Signal Transduct Target Ther. 2019 Sep 20;4:35. doi: 10.1038/s41392-019-0070-9. eCollection 2019. Signal Transduct Target Ther. 2019. PMID: 31637014 Free PMC article. Review.
Chimeric antigen receptor modified T-cells for cancer treatment.
Han X, Wang Y, Han WD. Han X, et al. Among authors: han wd. Chronic Dis Transl Med. 2018 Sep 18;4(4):225-243. doi: 10.1016/j.cdtm.2018.08.002. eCollection 2018 Dec. Chronic Dis Transl Med. 2018. PMID: 30603741 Free PMC article.
Long-term safety and efficacy of CART-20 cells in patients with refractory or relapsed B-cell non-Hodgkin lymphoma: 5-years follow-up results of the phase I and IIa trials.
Zhang WY, Liu Y, Wang Y, Wang CM, Yang QM, Zhu HL, Han WD. Zhang WY, et al. Among authors: han wd. Signal Transduct Target Ther. 2017 Oct 9;2:17054. doi: 10.1038/sigtrans.2017.54. eCollection 2017. Signal Transduct Target Ther. 2017. PMID: 29263931 Free PMC article. No abstract available.
58 results